SCHEMBL20920366

SCHEMBL20920366

CC(C)(C)OC(=O)N1C[C@H]2C[C@H](OCc3ccccc3Cl)C[C@H]2C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.57
MGLL Q99685 2/20 0.57
NR1H2 P55055 1/20 0.48
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
JAK2 O60674 1/20 0.44
JAK1 P23458 1/20 0.44
MAPT P10636 1/20 0.44
NAMPT P43490 1/20 0.42
KCNK3 O14649 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
KDM1A O60341 1/20 0.41
CARM1 Q86X55 1/20 0.41
PRMT6 Q96LA8 1/20 0.41
GPR119 Q8TDV5 1/20 0.40
STS P08842 1/20 0.40
PRMT5 O14744 1/20 0.40
WDR77 Q9BQA1 1/20 0.40
EPHX2 P34913 1/20 0.40
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24970468 1.00 FAAH (0.57) FAAHMGLLNR1H2KEAP1NFE2L2
SCHEMBL20567053 1.00 FAAH (0.57) FAAHMGLLNR1H2KEAP1NFE2L2
SCHEMBL25640104 1.00 FAAH (0.57) FAAHMGLLNR1H2KEAP1NFE2L2
SCHEMBL20567052 1.00 FAAH (0.57) FAAHMGLLNR1H2KEAP1NFE2L2
SCHEMBL25640092 1.00 FAAH (0.57) FAAHMGLLNR1H2KEAP1NFE2L2
SCHEMBL20920387 0.87 FAAH (0.51) FAAHMGLLNR1H2KEAP1NFE2L2
SCHEMBL24970046 0.87 FAAH (0.51) FAAHMGLLNR1H2KEAP1NFE2L2
SCHEMBL24969839 0.87 FAAH (0.51) FAAHMGLLNR1H2KEAP1NFE2L2
SCHEMBL30218721 0.87 FAAH (0.51) FAAHMGLLNR1H2KEAP1NFE2L2
SCHEMBL30218772 0.86 NR1H2 (0.45) FAAHMGLLNR1H2JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219897-A1 PYRAZOLE MAGL INHIBITORS H. LUNDBECK A/S (DK) 2023-07-13 US disclosed
US-20230219897-A1 PYRAZOLE MAGL INHIBITORS H. LUNDBECK A/S (DK) 2023-07-13 US disclosed
EP-4198024-A1 PYRAZOLE MAGL INHIBITORS H. Lundbeck A/S (DK) 2023-06-21 EP disclosed
US-11655217-B2 Pyrazole MAGL inhibitors H. LUNDBECK A/S (DK) 2023-05-23 US disclosed
US-11655217-B2 Pyrazole MAGL inhibitors H. LUNDBECK A/S (DK) 2023-05-23 US disclosed
EP-3630744-B1 PYRAZOLE MAGL INHIBITORS H LUNDBECK AS (DK) 2023-01-25 EP disclosed
US-20210053960-A1 PYRAZOLE MAGL INHIBITORS H. LUNDBECK A/S (DK) 2021-02-25 US disclosed
US-10927105-B1 Pyrazole MAGL inhibitors LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) 2021-02-23 US disclosed
US-10266497-B2 Pyrazole MAGL inhibitors ABIDE THERAPEUTICS, INC. (US) 2019-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219897-A1 PYRAZOLE MAGL INHIBITORS MGLL, PNLIP, LPL FAAH 33/4885MGLL 1/4885NR1H2 355/4885
US-10266497-B2 Pyrazole MAGL inhibitors MGLL, PNLIP, LPL FAAH 33/4885MGLL 1/4885NR1H2 355/4885
US-20210053960-A1 PYRAZOLE MAGL INHIBITORS MGLL, PNLIP, LPL FAAH 33/4885MGLL 1/4885NR1H2 355/4885
US-11655217-B2 Pyrazole MAGL inhibitors MGLL, PNLIP, LPL FAAH 32/4885MGLL 1/4885NR1H2 423/4885
US-10927105-B1 Pyrazole MAGL inhibitors MGLL, PNLIP, LPL FAAH 33/4885MGLL 1/4885NR1H2 355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.